abstract |
The invention relates to fluorobenzamide derivatives of the formula n n nwherein R 1 , R 2 , R 3 R 4 , R 5 , R 6 and R 7 are as defined herein. =,n n The compounds of the invention are selective monoamine oxidase B inhibitors and therefore they are suitable for the treatment of diseases mediated by monoamine oxidase B, such as Alzheimer's disease or senile dementia. |